Mononeuritis multiplex

Burns TM, Schaublin GA, Dyck PJ. Vasculitic neuropathies. Neurol Clin. 2007 Feb;25(1):89-113. Abstract

Rudnicki SA, Dalmau J. Paraneoplastic syndromes of the peripheral nerves. Curr Opin Neurol. 2005 Oct;18(5):598-603. Abstract

1. Collins MP, Kissel JT. Neuropathies with systemic vasculitis. In: Dyck PJ, Thomas PK, eds. Peripheral neuropathy. 4th ed. Vol. 2. Philadelphia, PA: Elsevier Saunders; 2005:2335-2404.

2. Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum. 1994 Feb;37(2):187-92. Abstract

3. Said G, Lacroix-Ciaudo C, Fujimura H, et al. The peripheral neuropathy of necrotizing arteritis: a clinicopathological study. Ann Neurol. 1988 May;23(5):461-5. Abstract

4. Hawke SH, Davies L, Pamphlett R, et al. Vasculitic neuropathy: a clinical and pathological study. Brain. 1991 Oct;114 ( Pt 5):2175-90. Abstract

5. Mathew L, Talbot K, Love S, et al. Treatment of vasculitic peripheral neuropathy: a retrospective analysis of outcome. QJM. 2007 Jan;100(1):41-51. Abstract

6. Langford CA. Vasculitis. J Allergy Clin Immunol. 2003 Feb;111(2 Suppl):S602-12. Abstract

7. Kamesh L, Harper L, Savage CO. ANCA-positive vasculitis. J Am Soc Nephrol. 2002 Jul;13(7):1953-60.Full text  Abstract

8. Dyck PJ, Benstead TJ, Conn, DL, et al. Nonsystemic vasculitic neuropathy. Brain. 1987 Aug;110 ( Pt 4):843-53. Abstract

9. Stone JH. Polyarteritis nodosa. JAMA. 2002 Oct 2;288(13):1632-9. Abstract

10. Cattaneo L, Chierici E, Pavone L, et al. Peripheral neuropathy in Wegener's granulomatosis, Churg-Strauss syndrome and microscopic polyangiitis. J Neurol Neurosurg Psychiatr. 2007 Oct;78(10):1119-23. Abstract

11. Nishino H, Rubino FA, DeRemee RA, et al. Neurological involvement in Wegener's granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic. Ann Neurol. 1993 Jan;33(1):4-9. Abstract

12. Delalande S, de Seze J, Fauchais AL, et al. Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients. Medicine (Baltimore). 2004 Sep;83(5):280-91. Abstract

13. Ramos-Casals M, Nardi N, Lagrutta M, et al. Vasculitis in systemic lupus erythematosus: prevalence and clinical characteristics in 670 patients. Medicine (Baltimore). 2006 Mar;85(2):95-104. Abstract

14. Genta MS, Genta RM, Gabay C. Systemic rheumatoid vasculitis: a review. Semin Arthritis Rheum. 2006 Oct;36(2):88-98. Abstract

15. Vollertsen RS, Conn DL, Ballard DJ, et al. Rheumatoid vasculitis: survival and associated risk factors. Medicine (Baltimore). 1986 Nov;65(6):365-75. Abstract

16. Burns TM. Vasculitic neuropathy. Continuum. 2003;9:146-59.

17. Chapelon C, Ziza JM, Piette JC, et al. Neurosarcoidosis: signs, course and treatment in 35 confirmed cases. Medicine (Baltimore). 1990 Sep;69(5):261-76. Abstract

18. Golbus J, McCune WJ. Giant cell arteritis and peripheral neuropathy: a report of 2 cases and review of the literature. J Rheumatol. 1987 Feb;14(1):129-34. Abstract

19. Chan WM, Liu DT, Chan AY, et al. ANCA-associated giant cell arteritis presenting with mononeuritis multiplex and central retinal artery occlusion: a case report. Rheumatology (Oxford). 2004 Apr;43(4):529-31. Abstract

20. Campbell SB, Hawley CM, Staples C. Mononeuritis multiplex complicating Henoch-Schonlein purpura. Aust N Z J Med. 1994 Oct;24(5):580. Abstract

21. Griffin JW. Vasculitic neuropathies. Rheum Dis Clin North Am. 2001;27:751-760. Abstract

22. Olney RK. AAEM minimonograph #38: neuropathies in connective tissue disease. Muscle Nerve. 1992 May;15(5):531-42. Abstract

23. Said G, Lacroix C. Primary and secondary vasculitic neuropathy. J Neurol. 2005;252:633-641. Abstract

24. Moore PM. Immune mechanisms in the primary and secondary vasculitides. J Neurol Sci. 1989 Nov;93(2-3):129-45. Abstract

25. Griem P, Wulferink M, Sachs B, et al. Allergic and autoimmune reactions to xenobiotics: how do they arise? Immunol Today. 1998 Mar;19(3):133-41. Abstract

26. Said G. Necrotizing peripheral nerve vasculitis. Neurol Clin. 1997 Nov;15(4):835-48. Abstract

27. Delaney P. Neurologic manifestations in sarcoidosis: review of the literature, with a report of 23 cases. Ann Intern Med. 1977 Sep;87(3):336-45. Abstract

28. Cacoub P, Maisonobe T, Thibault V, et al. Systemic vasculitis in patients with hepatitis C. J Rheumatol. 2001 Jan;28(1):109-18. Abstract

29. Burns TM, Schaublin GA, Dyck PJ. Vasculitic neuropathies. Neurol Clin. 2007 Feb;25(1):89-113. Abstract

30. Ten Holder SM, Joy MS, Falk RJ, et al. Cutaneous and systemic manifestations of drug-induced vasculitis. Ann Pharmacother. 2002 Jan;36(1):130-47. Abstract

31. Birnbaum J. Infliximab-associated neuropathy in RA patients - the importance of considering the diagnosis of mononeuritis multiplex. Clin Rheumatol. 2007 Feb;26(2):281-2. Abstract

32. Mauermann ML, Ryan ML, Moon JS, et al. Case of mononeuritis multiplex onset with rituximab therapy for Waldenstrom's macroglobulinemia. J Neurol Sci. 2007 Sep 15;260(1-2):240-3. Abstract

33. World Health Organization. Leprosy prevalence rates: data reported to WHO as of January 2012 [internet publication].Full text

34. Garg S, Wright A, Reichwein R, et al. Mononeuritis multiplex secondary to sarcoidosis. Clin Neurol Neurosurg. 2005 Feb;107(2):140-3. Abstract

35. Gwathmey KG, Burns TM, Collins MP, et al. Vasculitic neuropathies. Lancet Neurol. 2014 Jan;13(1):67-82. Abstract

36. Said G. Lyme disease. In: Dyck PJ, Thomas PK, eds. Peripheral neuropathy. 4th ed. Vol. 2. Philadelphia, PA: Elsevier Saunders; 2005:2109-16.

37. Vincent D, Gombert B, Vital A, et al. A case of mononeuropathy multiplex with type II cryoglobulinemia, necrotizing vasculitis and low grade B cell lymphoma. Clin Neuropathol. 2007 Jan-Feb;26(1):28-31. Abstract

38. Monti G, Galli M, Invernizzi F, et al. Cryoglobulinaemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease. GISC. Italian Group for the Study of Cryoglobulinaemias. QJM. 1995 Feb;88(2):115-26. Abstract

39. Hagen EC, Daha MR, Hermans J, et al; EC/BCR Project for ANCA Assay Standardization. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. Kidney Int. 1998 Mar;53(3):743-53.Full text  Abstract

40. Noth I, Strek ME, Leff AR. Churg-Strauss syndrome. Lancet. 2003 Feb 15;361(9357):587-94. Abstract

41. Said G, Lacroix C. Sarcoid neuropathy. In: Dyck PJ, Thomas PK, eds. Peripheral neuropathy. 4th ed. Vol. 2. Philadelphia, PA: Elsevier Saunders; 2005:2415-25.

42. Collins MP, Mendell JR, Periquet MI, et al. Superficial peroneal nerve/peroneus brevis muscle biopsy in vasculitic neuropathy. Neurology. 2000 Sep 12;55(5):636-43. Abstract

43. Vital C, Vital A, Canron MH, et al. Combined nerve and muscle biopsy in the diagnosis of vasculitic neuropathy. A 16-year retrospective study of 202 cases. J Peripher Nerv Syst. 2006 Mar;11(1):20-9. Abstract

44. Kawakami T, Soma Y, Kawasaki K, et al. Initial cutaneous manifestations consistent with mononeuropathy multiplex in Churg-Strauss syndrome. Arch Dermatol. 2005 Jul;141(7):873-8. Abstract

45. Lee JE, Shun CT, Hsieh SC, et al. Skin denervation in vasculitic neuropathy. Arch Neurol. 2005 Oct;62(10):1570-3.Full text  Abstract

46. Sabin TD, Swift TR, Jacobson RR. Leprosy. In: Dyck PJ, Thomas PK, eds. Peripheral neuropathy. 4th ed. Vol. 2. Philadelphia, PA: Elsevier Saunders; 2005:2081-2108.

47. Harrison TR, Fauci AS, Braunwald E, et al. Harrison's principles of internal medicine. 14th ed. Vol 2. New York, NY: McGraw-Hill; 1997:1874-1928.

48. Stanson AW, Friese JL, Johnson CM, et al. Polyarteritis nodosa; spectrum of angiographic findings. Radiographics. 2001 Jan-Feb;21(1):151-9.Full text  Abstract

49. Pasnoor M, Dimachkie MM, Barohn RJ. Diabetic neuropathy part 2: proximal and asymmetric phenotypes. Neurol Clin. 2013 May;31(2):447-62. Abstract

50. Lau JY, Bird GL, Alexander GJ, et al. Effects of immunosuppressive therapy on hepatic expression of hepatitis B viral genome and gene products. Clin Invest Med. 1993 Jun;16(3):226-36. Abstract

51. Guillevin L, Cohen P, Larroche C, et al. Treatment of HBV-related polyarteritis nodosa with lamivudine and plasma exchanges: a prospective, multicenter, pilot trial in 10 patients. Annual Scientific Meeting, San Francisco, 2001; abstract 1311. Arthritis Rheum. 2001;44(Suppl 9):S271.Full text

52. Gupta S, Piraka C, Jaffe M. Lamivudine in the treatment of polyarteritis nodosa associated with acute hepatitis B. N Engl J Med. 2001 May 24;344(21):1645-6. Abstract

53. Boonyapisit K, Katirji B. Severe exacerbation of hepatitis C-associated vasculitic neuropathy following treatment with interferon alpha: a case report and literature review. Muscle Nerve. 2002 Jun;25(6):909-13. Abstract

54. American Association for the Study of Liver Diseases. HCV guidance: recommendations for testing, managing, and treating hepatitis C. May 2018 [internet publication].Full text

55. Verma, A. Epidemiology and clinical features of HIV-1 associated neuropathies. J Peripher Nerv Syst. 2001 Mar;6(1):8-13. Abstract

56. Rudnicki SA, Dalmau J. Paraneoplastic syndromes of the peripheral nerves. Curr Opin Neurol. 2005 Oct;18(5):598-603. Abstract

57. Koike H, Akiyama K, Saito T, et al. Intravenous immunoglobulin for chronic residual peripheral neuropathy in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome): a multicenter, double-blind trial. J Neurol. 2015 Mar;262(3):752-9.Full text  Abstract

58. Scott TF, Stern BJ. Treatment of neurosarcoidosis. In: Noseworthy JH, ed. Neurological therapeutics principles and practice. 2nd ed. Vol. 2. London: Informa Healthcare Books; 2006:1602-07.

59. Molloy ES, Langford CA. Advances in the treatment of small vessel vasculitis. Rheum Dis Clin North Am. 2006 Feb;32(1):157-72, x. Abstract

60. Saadoun D, Thibault V, Si Ahmed SN, et al. Sofosbuvir plus ribavirin for hepatitis C virus-associated cryoglobulinaemia vasculitis: VASCUVALDIC study. Ann Rheum Dis. 2016 Oct;75(10):1777-82. Abstract

61. Saadoun D, Pol S, Ferfar Y, et al. Efficacy and safety of sofosbuvir plus daclatasvir for treatment of HCV-associated cryoglobulinemia vasculitis. Gastroenterology. 2017 Jul;153(1):49-52.e5.Full text  Abstract

62. Cohen Aubart F, Bouvry D, Galanaud D, et al. Long-term outcomes of refractory neurosarcoidosis treated with infliximab. J Neurol. 2017 May;264(5):891-97. Abstract

63. Gelfand JM, Bradshaw MJ, Stern BJ, et al. Infliximab for the treatment of CNS sarcoidosis: A multi-institutional series. Neurology. 2017 Nov 14;89(20):2092-2100.Full text  Abstract

64. Chan TM, Tse KC, Tang CS, et al. Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis. J Am Soc Nephrol. 2005 Apr;16(4):1076-84.Full text  Abstract

65. Hu W, Liu C, Xie H, et al. Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement. Nephrol Dial Transplant. 2008 Apr;23(4):1307-12. Abstract

66. Collins MP, Periquet MI, Mendell JR, et al. Nonsystemic vasculitic neuropathy: insights from a clinical cohort. Neurology. 2003 Sep 9;61(5):623-30. Abstract